Track the 盘龙药业 share price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 盘龙药业 has logged 3 public disclosures. Market capitalisation: €2.8bn. The latest transaction was disclosed on 12 March 2026 (Sale). Among the most active insiders: 朱文锋. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
盘龙药业 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of innovative medicines.